Across the country, the One Big, Beautiful Bill Act (OBBBA) is making headlines for its impact on research and innovation. Still, one provision matters especially to clinical trial participants: the change in how stipends are reported for tax purposes.
When most people hear the words “clinical trial”, their first thought is often something like, “I don’t want to be a guinea pig.” It’s a natural reaction, after all, the idea of testing new treatments or devices can sound intimidating.
With obesity affecting over 40% of U.S. adults, the need for clinical research has never been greater. See how Tribe Clinical Research is leading the way.
